Windtree Therapeutics Inc (WINT)

[micar]

Came out this morning at 10 am: Windtree Therapeutics Inc.'s board of directors has approved a 1-for-50 reverse stock split of the company's issued and outstanding stock.
On Friday, the reverse split will become effective at 12:01 a.m. ET and shares will open for trading on a split- adjusted basis, the Warrington, Pa. -based cardiovascular disorder-focused biotechnology company said Thursday.
Windtree expects the reverse stock split to increase the market price per share of the stock, bringing the company into compliance with Nasdaq's listing requirements.
The reverse stock split will reduce the number of shares of outstanding stock to about 900,000 shares from about 44.5 million shares, Windtree said.